Jpmorgan Chase & Co »

Onconova Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Onconova Therapeutics (ONTX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Onconova Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Onconova Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onconova Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $27 36 0.75
2023-09-30 $18 25 0.72
2022-03-31 $9.0k 4.8k 1.87

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Onconova Therapeutics

Vanguard Group
Two Sigma Advisers
Two Sigma Investments
Beacon Pointe Advisors
Millennium Management
Mutual Advisors
UBS Group
Edmond De Rothschild Holding
Bank of America Corporation
Royal Bank of Canada
Wells Fargo & Company
TD Waterhouse Canada
Jpmorgan Chase & Co
Advisor Group Holdings

View all funds holding Onconova Therapeutics